Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
14.66 EUR | -1.08% | -3.43% | +49.29% |
29/04 | Abivax: share price rises as two analysts express optimism | CF |
29/04 | Piper Sandler Starts Abivax With Overweight Rating, $42 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.29% | 999M | |
+1.55% | 42.86B | |
+11.70% | 42.74B | |
+45.21% | 41.36B | |
-8.83% | 27.68B | |
+8.14% | 25.15B | |
-22.79% | 18.63B | |
+30.76% | 12.37B | |
-2.17% | 11.92B | |
+7.49% | 11.21B |
- Stock Market
- Equities
- ABVX Stock
- News Abivax
- Abivax Gets EU Support To Advance Ulcerative Colitis Drug Into Late-Stage Trial